Oligometastatic Disease Clinical Trial
Official title:
IT2023-08-ATKINS-ATHERO-RT: Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography
The prospective single-arm pilot study, ATHERO-RT: Real-Time Atherosclerosis Activity after Thoracic Radiotherapy using Sodium Fluoride Positron Emission Tomography, will aim to: 1. To deploy first-in-kind application of fluorine 18-sodium fluoride (18F-NaF) PET (Positron Emission Tomography) /MRI (Magnetic Resonance Imaging) imaging to detect real-time atherosclerosis activity at the time of cancer diagnosis and after cardiac radiation exposure 2. To detect longitudinal changes in clonal hematopoiesis (CH) genetic architecture following thoracic RT (Radiation Therapy) in patients at high risk of cardiac dysfunction, and 3. To measure perturbations in the immune-modulatory and metabolic states following thoracic RT (Radiation Therapy) exposure in patients at high risk of cardiac dysfunction. Eligible patients will be adults (≥18 years old) with Stage II-III or oligo-metastatic stage IV malignancy (any histology) at high risk for RT-associated cardiac toxicity (defined as receiving ≥30 Gy (Gray) RT where the heart is in the treatment field54). The study will enroll a total of 10 subjects, recruited from Cedars-Sinai Medical Center. The primary endpoint will be successful completion of 18F-NaF PET imaging at the baseline and 6-month post-RT time points. Blood will be collected at baseline, end of RT, and 6-months post-RT.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06190782 -
Local Therapy for Oligometastatic Esophageal Squamous Cell Cancer Patients Treated With PD-1 Inhibitor: a Prospective, Randomized, Phase III Clinical Trial.
|
Phase 3 | |
| Recruiting |
NCT05377047 -
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
|
N/A | |
| Recruiting |
NCT05223803 -
TERPS Trial for de Novo Oligometastic Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT04617457 -
Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas
|
Phase 2 | |
| Recruiting |
NCT04821765 -
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
|
Phase 2 | |
| Recruiting |
NCT05679427 -
Ablative Radiosurgery vs Stereotactic RT in 5 Fractions With SIB for Oligometastatic Bone Lesions
|
N/A | |
| Recruiting |
NCT05277844 -
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
|
Phase 2 | |
| Active, not recruiting |
NCT05951127 -
Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC
|
N/A | |
| Active, not recruiting |
NCT05101824 -
Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease
|
N/A | |
| Recruiting |
NCT04748042 -
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
|
Phase 2 | |
| Not yet recruiting |
NCT06122480 -
Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT05784428 -
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
|
N/A | |
| Recruiting |
NCT04593381 -
Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer
|
N/A | |
| Terminated |
NCT01345539 -
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation
|
Phase 2 | |
| Recruiting |
NCT05846646 -
Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC
|
Phase 2 | |
| Recruiting |
NCT04973007 -
Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
|
Phase 4 | |
| Recruiting |
NCT05917431 -
Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC
|
Phase 2 | |
| Not yet recruiting |
NCT05903261 -
Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors
|
||
| Not yet recruiting |
NCT05375708 -
Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites
|
Phase 2 | |
| Recruiting |
NCT06299852 -
Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer
|
N/A |